Literature DB >> 80287

Epidemiology of endemic goitre in western Colombia.

E Gaitan, H Merino, G Rodriguez, P Medina, J D Meyer, T A DeRouen, R MacLennan.   

Abstract

This paper reports on recent epidemiological observations in western Colombia, which further demonstrate the presence of naturally-occurring goitrogens contaminating water supplies in areas where goitre persists despite prolonged and continuous iodine supplementation. 'Prospective' and 'cross-sectional' studies in 41 localities where the populations have been on a uniform and adequate iodine supplementation for the last 10-20 years indicate that, in the endemia of western Colombia, environmental factors other than nutritional iodine deficiency are responsible for differences in goitre prevalence. Further epidemiological studies to determine the causal factors for the persistence of the endemia established a correlation between the sources of drinking water and goitre prevalence rates. Organic compounds containing sulfur with marked thionamide-like antithyroid activity were isolated from water supplying endemic goitre districts, and results are presented supporting the hypothesis that sedimentary rocks rich in organic matter are the main source of water-borne goitrogens. Bacteriological investigations showed that the presence of Klebsiella pneumoniae in drinking water and bacterial concentration were related significantly with goitre prevalence only in the presence of other variables, particularly the presence of sedimentary rocks. In the light of these epidemiological observations and experimental studies it may be concluded that, at present, endemic goitre in western Colombia is not due to nutritional iodine deficiency, but that water supplies are contaminated with sulfur-bearing organic compounds with thionamide-like antithyroid activity most probably deriving from sedimentary rocks rich in organic matter and that these compounds are the main factor underlying the endemia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80287      PMCID: PMC2395584     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  24 in total

1.  EPIDEMIOLOGIC AND METABOLIC STUDIES OF A GOITER ENDEMIC IN EASTERN KENTUCKY.

Authors:  W T LONDON; D A KOUTRAS; A PRESSMAN; R L VOUGHT
Journal:  J Clin Endocrinol Metab       Date:  1965-08       Impact factor: 5.958

2.  Naturally occurring goitrogens.

Authors:  F W CLEMENTS
Journal:  Br Med Bull       Date:  1960-05       Impact factor: 4.291

3.  Seasonal epidemics of endemic goitre in Tasmania.

Authors:  H B GIBSON; J F HOWELER; F W CLEMENTS
Journal:  Med J Aust       Date:  1960-06-04       Impact factor: 7.738

4.  Plant thioglycosides and the problem of endemic goitre in Australia.

Authors:  H S BACHELARD; V M TRIKOJUS
Journal:  Nature       Date:  1960-01-09       Impact factor: 49.962

5.  Goitrogenic effect of cow's milk from the goitre district of Finland.

Authors:  P PELTOLA
Journal:  Acta Endocrinol (Copenh)       Date:  1960-05

6.  Elevated thyroidal 1-131 uptake in the absence of goiter in isolated Venezuelan Indians.

Authors:  M ROCHE
Journal:  J Clin Endocrinol Metab       Date:  1959-11       Impact factor: 5.958

7.  Effect of cow's milk from the goitre endemia district of Finland on thyroid function.

Authors:  P PELTOLA; F E KRUSIUS
Journal:  Acta Endocrinol (Copenh)       Date:  1960-04

8.  Technique of endemic goitre surveys.

Authors:  C PEREZ; N S SCRIMSHAW; J A MUNOZ
Journal:  Monogr Ser World Health Organ       Date:  1960

9.  Antithyroid compound(s) produced by Escherichia coli: preliminary report.

Authors:  R L Vought; F A Brown; K H Sibinovic
Journal:  J Clin Endocrinol Metab       Date:  1974-05       Impact factor: 5.958

10.  Antigoitrogenic effect of casein.

Authors:  E Gaitán; H Merino
Journal:  Acta Endocrinol (Copenh)       Date:  1976-12
View more
  1 in total

Review 1.  Endemic goiter and endemic thyroid disorders.

Authors:  E Gaitan; N C Nelson; G V Poole
Journal:  World J Surg       Date:  1991 Mar-Apr       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.